Our team is developing a ground-breaking tool for detecting the cerebral amyloid status as based on PET imaging, a key biomarker of Alzheimer's disease. Imagine the impact this will have on finding a cure.
Step 1 :
The retina is a light-sensitive layer of tissue that lines the back of the eye. Attached directly to the brain, it’s not surprising that the eye provides accurate insights into neurological pathologies.
Optina Diagnostics’ hyperspectral camera collects and processes the light intensity for a large number (225) of contiguous spectral bands at very high speeds.
Step 2 :
With the collection of sequential images of the retina, healthcare professionals and researchers are able to obtain monochromatic illumination wavelengths to build a hyperspectral cube of data. While providing a method for observing anatomical structures, this process also paves the way for an in-depth understanding of patient data through the use of spectral signatures – a breakthrough in localizing and quantifying specific biomolecules in the fundus.
Step 3 :
Every pixel in an image contains a continuous spectrum (in radiance or reflectance) where this vital information is then used to characterize biomarkers in the fundus with greater precision than ever before. The large volume of data is ideal for machine learning algorithm development.
Alzheimer’s is the 6th leading cause of death in the US.